Trial NCT04660045

View at ClinicalTrials.gov 
Org. Study IDs: 20-11022876

Last trial update was posted on 2022-04-05

MeSH Interventions

Acalabrutinib

MeSH Conditions

Leukemia, Lymphocytic, Chronic, B-Cell

Other Conditions

CLL/SLL Chronic Lymphocytic Leukemia

Stopping Reasons

Company supplying drug/funding ceased support.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID